PTH and postmenopausal osteoporosis: The administration of parathyroid hormone (PTH) has been demonstrated to enhance bone mineral density (BMD) in estrogen‐deficient women, thereby reducing the risk of fractures in those with postmenopausal osteoporosis [4, 5, 6, 7].